The Current Ratio as of December 2025 (TTM) for Autobio Diagnostics Co., Ltd. (603658.SS) is 2.58

According to Autobio Diagnostics Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.58. This represents a change of 3.08% compared to the average of 2.50 of the last 4 quarters.

Autobio Diagnostics Co., Ltd. (603658.SS) Historical Current Ratio (quarterly & annually)

How has 603658.SS Current Ratio performed in the past?

The mean historical Current Ratio of Autobio Diagnostics Co., Ltd. over the last ten years is 3.30. The current 2.58 Current Ratio has changed 7.72% with respect to the historical average. Over the past ten years (40 quarters), 603658.SS's Current Ratio was at its highest in in the September 2016 quarter at 8.04. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Autobio Diagnostics Co., Ltd. (603658.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Autobio Diagnostics Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Autobio Diagnostics Co., Ltd. (603658.SS) Average Current Ratio

How has 603658.SS Current Ratio performed in the past?

The current Current Ratio of Autobio Diagnostics Co., Ltd. (603658.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Autobio Diagnostics Co., Ltd. (603658.SS) Current Ratio vs. Peers

How is 603658.SS’s Current Ratio compared to its peers?

Autobio Diagnostics Co., Ltd.’s Current Ratio is less than BGI Genomics Co., Ltd. (2.81), less than Joincare Pharmaceutical Group Industry Co.,Ltd. (2.63), less than iRay Technology Company Limited (3.87), less than Tasly Pharmaceutical Group Co., Ltd (3.82), greater than China National Medicines Corporation Ltd. (2.15), less than Hubei Jumpcan Pharmaceutical Co., Ltd. (5.32), greater than Winner Medical Co., Ltd. (1.69), greater than DaShenLin Pharmaceutical Group Co., Ltd. (0.96), less than Double Medical Technology Inc. (3.77), greater than Liaoning Cheng Da Co., Ltd. (1.10),

Build a custom stock screener for Autobio Diagnostics Co., Ltd. (603658.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Autobio Diagnostics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Autobio Diagnostics Co., Ltd. (603658.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Autobio Diagnostics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.